| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 113 | 2024 | 1600 | 10.050 |
Why?
|
| Bone Density | 182 | 2024 | 3534 | 9.820 |
Why?
|
| Hip Fractures | 85 | 2024 | 989 | 8.790 |
Why?
|
| Osteoporotic Fractures | 42 | 2024 | 409 | 7.170 |
Why?
|
| Accidental Falls | 47 | 2023 | 1056 | 3.900 |
Why?
|
| Nursing Homes | 36 | 2023 | 1082 | 3.430 |
Why?
|
| Bone Density Conservation Agents | 26 | 2024 | 796 | 3.180 |
Why?
|
| Absorptiometry, Photon | 64 | 2024 | 1736 | 3.070 |
Why?
|
| Sarcopenia | 27 | 2024 | 372 | 3.010 |
Why?
|
| Fractures, Bone | 40 | 2024 | 2041 | 2.870 |
Why?
|
| Aorta, Abdominal | 23 | 2024 | 625 | 2.650 |
Why?
|
| Bone and Bones | 33 | 2024 | 2560 | 2.560 |
Why?
|
| Spinal Fractures | 25 | 2023 | 702 | 2.080 |
Why?
|
| Homes for the Aged | 20 | 2021 | 272 | 2.000 |
Why?
|
| Osteoporosis, Postmenopausal | 20 | 2019 | 393 | 1.940 |
Why?
|
| Hand Strength | 19 | 2021 | 452 | 1.840 |
Why?
|
| Aortic Diseases | 14 | 2023 | 736 | 1.680 |
Why?
|
| Aging | 46 | 2024 | 8651 | 1.650 |
Why?
|
| Genome-Wide Association Study | 69 | 2023 | 12626 | 1.640 |
Why?
|
| Muscle Strength | 14 | 2024 | 619 | 1.520 |
Why?
|
| Vibration | 6 | 2016 | 327 | 1.520 |
Why?
|
| Inheritance Patterns | 7 | 2018 | 340 | 1.490 |
Why?
|
| Aged, 80 and over | 189 | 2024 | 58995 | 1.470 |
Why?
|
| Vitamin D | 26 | 2018 | 3291 | 1.440 |
Why?
|
| Aged | 320 | 2024 | 169152 | 1.430 |
Why?
|
| Lumbar Vertebrae | 38 | 2023 | 1868 | 1.360 |
Why?
|
| Spine | 23 | 2021 | 1111 | 1.270 |
Why?
|
| Femur Neck | 23 | 2020 | 312 | 1.250 |
Why?
|
| Bone Diseases, Metabolic | 6 | 2023 | 409 | 1.240 |
Why?
|
| Diphosphonates | 10 | 2023 | 638 | 1.230 |
Why?
|
| Consensus | 11 | 2024 | 3113 | 1.140 |
Why?
|
| Polymorphism, Single Nucleotide | 58 | 2021 | 15789 | 1.120 |
Why?
|
| Alendronate | 11 | 2021 | 173 | 1.100 |
Why?
|
| Female | 368 | 2024 | 391270 | 1.070 |
Why?
|
| Thoracic Vertebrae | 14 | 2019 | 597 | 1.070 |
Why?
|
| Calcinosis | 15 | 2018 | 1476 | 1.050 |
Why?
|
| Genetic Loci | 14 | 2021 | 2618 | 1.040 |
Why?
|
| Humans | 479 | 2024 | 760621 | 1.020 |
Why?
|
| Intra-Abdominal Fat | 3 | 2023 | 608 | 1.010 |
Why?
|
| Geriatric Assessment | 12 | 2017 | 1405 | 1.010 |
Why?
|
| Male | 317 | 2024 | 359744 | 1.000 |
Why?
|
| Calcium, Dietary | 12 | 2018 | 531 | 0.960 |
Why?
|
| Frail Elderly | 12 | 2022 | 752 | 0.930 |
Why?
|
| Postural Balance | 11 | 2015 | 617 | 0.920 |
Why?
|
| Diet | 29 | 2024 | 8010 | 0.900 |
Why?
|
| Muscle Weakness | 9 | 2021 | 413 | 0.880 |
Why?
|
| Quantitative Trait Loci | 23 | 2020 | 2101 | 0.870 |
Why?
|
| Cohort Studies | 97 | 2024 | 41335 | 0.840 |
Why?
|
| Risk Factors | 123 | 2024 | 74359 | 0.800 |
Why?
|
| Methylmalonic Acid | 1 | 2021 | 49 | 0.770 |
Why?
|
| Musculoskeletal System | 4 | 2019 | 181 | 0.770 |
Why?
|
| Finite Element Analysis | 5 | 2018 | 428 | 0.760 |
Why?
|
| Dietary Proteins | 10 | 2017 | 949 | 0.740 |
Why?
|
| Vitamin B Complex | 2 | 2021 | 297 | 0.710 |
Why?
|
| Longevity | 9 | 2024 | 1050 | 0.710 |
Why?
|
| Protective Devices | 3 | 2010 | 72 | 0.710 |
Why?
|
| Middle Aged | 191 | 2024 | 220352 | 0.700 |
Why?
|
| Bone Remodeling | 6 | 2017 | 580 | 0.690 |
Why?
|
| Dietary Supplements | 17 | 2018 | 3392 | 0.680 |
Why?
|
| Mobility Limitation | 9 | 2021 | 402 | 0.680 |
Why?
|
| Mannose-Binding Lectin | 1 | 2020 | 146 | 0.680 |
Why?
|
| Dairy Products | 6 | 2022 | 494 | 0.670 |
Why?
|
| Hip | 9 | 2012 | 251 | 0.670 |
Why?
|
| Independent Living | 10 | 2023 | 570 | 0.660 |
Why?
|
| Muscle, Skeletal | 14 | 2024 | 4925 | 0.660 |
Why?
|
| Thinness | 4 | 2017 | 491 | 0.650 |
Why?
|
| Radius | 8 | 2024 | 440 | 0.650 |
Why?
|
| Activities of Daily Living | 16 | 2023 | 2417 | 0.640 |
Why?
|
| Equipment and Supplies | 2 | 2012 | 275 | 0.640 |
Why?
|
| Body Composition | 16 | 2020 | 2419 | 0.640 |
Why?
|
| Longitudinal Studies | 42 | 2023 | 14495 | 0.630 |
Why?
|
| Genetic Predisposition to Disease | 28 | 2021 | 17790 | 0.620 |
Why?
|
| Protective Clothing | 2 | 2010 | 103 | 0.620 |
Why?
|
| National Institutes of Health (U.S.) | 5 | 2019 | 791 | 0.600 |
Why?
|
| Risk Assessment | 28 | 2024 | 24123 | 0.600 |
Why?
|
| Calcaneus | 6 | 2022 | 142 | 0.600 |
Why?
|
| Femur | 18 | 2015 | 1302 | 0.590 |
Why?
|
| Advisory Committees | 2 | 2024 | 788 | 0.560 |
Why?
|
| Vitamin D Deficiency | 6 | 2017 | 1379 | 0.550 |
Why?
|
| DNA Methylation | 11 | 2023 | 4373 | 0.540 |
Why?
|
| Sex Characteristics | 13 | 2018 | 2629 | 0.540 |
Why?
|
| RANK Ligand | 3 | 2014 | 318 | 0.540 |
Why?
|
| Genome, Human | 13 | 2021 | 4417 | 0.530 |
Why?
|
| Tomography, X-Ray Computed | 30 | 2024 | 20509 | 0.530 |
Why?
|
| Pelvic Bones | 3 | 2019 | 270 | 0.530 |
Why?
|
| Genetic Variation | 9 | 2021 | 6551 | 0.520 |
Why?
|
| Critical Pathways | 1 | 2019 | 475 | 0.510 |
Why?
|
| Carotenoids | 5 | 2024 | 620 | 0.510 |
Why?
|
| Phenotype | 25 | 2024 | 16546 | 0.510 |
Why?
|
| Kyphosis | 5 | 2019 | 237 | 0.500 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 374 | 0.490 |
Why?
|
| Incidence | 35 | 2024 | 21392 | 0.480 |
Why?
|
| Vitamin B 12 | 3 | 2021 | 522 | 0.480 |
Why?
|
| Genetic Linkage | 9 | 2010 | 2381 | 0.470 |
Why?
|
| Mendelian Randomization Analysis | 7 | 2024 | 998 | 0.470 |
Why?
|
| Vegetables | 6 | 2024 | 1196 | 0.470 |
Why?
|
| Sex Factors | 32 | 2021 | 10547 | 0.460 |
Why?
|
| Tibia | 8 | 2024 | 1065 | 0.460 |
Why?
|
| Dementia | 4 | 2024 | 2649 | 0.460 |
Why?
|
| Body Mass Index | 28 | 2024 | 12914 | 0.440 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2015 | 363 | 0.440 |
Why?
|
| GTPase-Activating Proteins | 1 | 2016 | 475 | 0.440 |
Why?
|
| Fruit | 6 | 2024 | 1160 | 0.440 |
Why?
|
| Adult | 109 | 2024 | 219994 | 0.430 |
Why?
|
| Muscles | 6 | 2023 | 1581 | 0.430 |
Why?
|
| Genomics | 7 | 2022 | 5794 | 0.430 |
Why?
|
| Calibration | 2 | 2019 | 816 | 0.430 |
Why?
|
| Vitamin K 1 | 4 | 2007 | 47 | 0.420 |
Why?
|
| Estradiol | 7 | 2018 | 1932 | 0.420 |
Why?
|
| Massachusetts | 29 | 2015 | 8803 | 0.420 |
Why?
|
| Testosterone | 9 | 2021 | 2470 | 0.420 |
Why?
|
| Medicare | 20 | 2023 | 6786 | 0.420 |
Why?
|
| Gait | 8 | 2021 | 812 | 0.410 |
Why?
|
| Quantitative Trait, Heritable | 6 | 2018 | 540 | 0.410 |
Why?
|
| Silicon | 3 | 2009 | 142 | 0.410 |
Why?
|
| Epigenesis, Genetic | 11 | 2023 | 3758 | 0.410 |
Why?
|
| Polymorphism, Genetic | 7 | 2014 | 4291 | 0.400 |
Why?
|
| Tai Ji | 3 | 2012 | 287 | 0.400 |
Why?
|
| Flavonols | 2 | 2023 | 83 | 0.400 |
Why?
|
| Long-Term Care | 5 | 2016 | 632 | 0.400 |
Why?
|
| Osteoprotegerin | 2 | 2014 | 177 | 0.400 |
Why?
|
| Age Factors | 39 | 2020 | 18416 | 0.400 |
Why?
|
| Patient Compliance | 6 | 2012 | 2688 | 0.400 |
Why?
|
| Calcium | 15 | 2022 | 5725 | 0.380 |
Why?
|
| Vitamin K | 4 | 2010 | 321 | 0.380 |
Why?
|
| Genotype | 23 | 2021 | 12960 | 0.380 |
Why?
|
| Homocysteine | 4 | 2013 | 640 | 0.380 |
Why?
|
| Postmenopause | 14 | 2019 | 2509 | 0.370 |
Why?
|
| Milk | 6 | 2022 | 443 | 0.370 |
Why?
|
| Genetic Pleiotropy | 4 | 2019 | 181 | 0.370 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2012 | 150 | 0.360 |
Why?
|
| Antihypertensive Agents | 3 | 2023 | 2061 | 0.360 |
Why?
|
| Atherosclerosis | 6 | 2022 | 3517 | 0.360 |
Why?
|
| Prospective Studies | 50 | 2024 | 54303 | 0.360 |
Why?
|
| Folic Acid | 3 | 2021 | 1309 | 0.360 |
Why?
|
| Cross-Sectional Studies | 43 | 2024 | 25942 | 0.350 |
Why?
|
| Linkage Disequilibrium | 10 | 2020 | 1996 | 0.350 |
Why?
|
| Proportional Hazards Models | 18 | 2020 | 12531 | 0.350 |
Why?
|
| LDL-Receptor Related Proteins | 2 | 2008 | 118 | 0.340 |
Why?
|
| Ascorbic Acid | 4 | 2023 | 655 | 0.340 |
Why?
|
| Sex Hormone-Binding Globulin | 5 | 2013 | 546 | 0.340 |
Why?
|
| Disabled Persons | 5 | 2018 | 1223 | 0.330 |
Why?
|
| Research Design | 8 | 2024 | 6180 | 0.330 |
Why?
|
| Estrogen Replacement Therapy | 10 | 2014 | 1206 | 0.330 |
Why?
|
| Alcoholic Beverages | 2 | 2009 | 264 | 0.330 |
Why?
|
| Benzodiazepines | 1 | 2015 | 1131 | 0.330 |
Why?
|
| Skilled Nursing Facilities | 3 | 2023 | 400 | 0.320 |
Why?
|
| Bone Resorption | 6 | 2017 | 720 | 0.320 |
Why?
|
| United States | 51 | 2023 | 72461 | 0.320 |
Why?
|
| Adipose Tissue | 7 | 2023 | 3301 | 0.320 |
Why?
|
| Bone Diseases | 1 | 2012 | 419 | 0.320 |
Why?
|
| Cardiovascular Diseases | 12 | 2024 | 15757 | 0.320 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2023 | 1006 | 0.320 |
Why?
|
| Wnt Proteins | 3 | 2015 | 719 | 0.310 |
Why?
|
| Body Fluid Compartments | 2 | 2019 | 50 | 0.300 |
Why?
|
| Follow-Up Studies | 37 | 2023 | 39261 | 0.300 |
Why?
|
| Estrogens | 7 | 2014 | 1520 | 0.300 |
Why?
|
| Resistance Training | 3 | 2021 | 185 | 0.290 |
Why?
|
| Radiography | 25 | 2014 | 6965 | 0.290 |
Why?
|
| Body Height | 3 | 2012 | 1570 | 0.280 |
Why?
|
| Family Characteristics | 1 | 2012 | 1001 | 0.280 |
Why?
|
| Reminder Systems | 1 | 2010 | 387 | 0.280 |
Why?
|
| Hand | 3 | 2017 | 903 | 0.280 |
Why?
|
| Coronary Artery Disease | 6 | 2024 | 6659 | 0.280 |
Why?
|
| Receptors, Calcitriol | 2 | 2000 | 359 | 0.270 |
Why?
|
| Vascular Diseases | 3 | 2023 | 1182 | 0.270 |
Why?
|
| Menarche | 4 | 2018 | 529 | 0.270 |
Why?
|
| Insulin-Like Growth Factor I | 7 | 2002 | 1928 | 0.260 |
Why?
|
| Eating | 6 | 2022 | 1539 | 0.260 |
Why?
|
| Habits | 1 | 2006 | 146 | 0.260 |
Why?
|
| Carbonated Beverages | 1 | 2006 | 209 | 0.250 |
Why?
|
| Alcohol Drinking | 7 | 2009 | 4013 | 0.250 |
Why?
|
| Life Style | 5 | 2020 | 3896 | 0.240 |
Why?
|
| Linear Models | 12 | 2021 | 5877 | 0.240 |
Why?
|
| Adiposity | 4 | 2023 | 1858 | 0.240 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5889 | 0.240 |
Why?
|
| Vitamins | 4 | 2023 | 1634 | 0.240 |
Why?
|
| Quadriceps Muscle | 2 | 2017 | 154 | 0.240 |
Why?
|
| Institutionalization | 2 | 1995 | 105 | 0.240 |
Why?
|
| Arteriosclerosis | 5 | 2002 | 1064 | 0.240 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2007 | 704 | 0.230 |
Why?
|
| Exercise | 7 | 2020 | 5787 | 0.230 |
Why?
|
| Confidence Intervals | 10 | 2016 | 2932 | 0.230 |
Why?
|
| Age Distribution | 9 | 2016 | 2893 | 0.230 |
Why?
|
| Alzheimer Disease | 7 | 2024 | 8547 | 0.230 |
Why?
|
| Mental Recall | 1 | 2010 | 1206 | 0.220 |
Why?
|
| Premenopause | 4 | 2013 | 1038 | 0.220 |
Why?
|
| Hyperhomocysteinemia | 1 | 2004 | 118 | 0.220 |
Why?
|
| Body Size | 4 | 2012 | 462 | 0.220 |
Why?
|
| CpG Islands | 5 | 2023 | 1221 | 0.220 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2004 | 119 | 0.220 |
Why?
|
| Retrospective Studies | 33 | 2024 | 80372 | 0.220 |
Why?
|
| Feeding Behavior | 6 | 2018 | 3185 | 0.210 |
Why?
|
| Smoking | 13 | 2016 | 9073 | 0.210 |
Why?
|
| Cross-Over Studies | 3 | 2015 | 2061 | 0.210 |
Why?
|
| Meta-Analysis as Topic | 6 | 2020 | 1376 | 0.210 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2002 | 24 | 0.210 |
Why?
|
| Leukotriene B4 | 2 | 1996 | 280 | 0.210 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 28 | 0.210 |
Why?
|
| Cause of Death | 5 | 2020 | 3725 | 0.210 |
Why?
|
| Quercetin | 1 | 2023 | 97 | 0.210 |
Why?
|
| Wounds and Injuries | 3 | 2014 | 2477 | 0.210 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2017 | 557 | 0.210 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2003 | 275 | 0.210 |
Why?
|
| Weight-Bearing | 3 | 2017 | 518 | 0.210 |
Why?
|
| Chromosome Mapping | 5 | 2020 | 4625 | 0.210 |
Why?
|
| Extracellular Matrix Proteins | 4 | 2019 | 829 | 0.200 |
Why?
|
| Predictive Value of Tests | 10 | 2020 | 15289 | 0.200 |
Why?
|
| Interleukin-6 | 4 | 2022 | 3215 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2015 | 10827 | 0.200 |
Why?
|
| Principal Component Analysis | 2 | 2012 | 940 | 0.200 |
Why?
|
| Heat-Shock Proteins | 2 | 2019 | 795 | 0.200 |
Why?
|
| Risk | 8 | 2013 | 9631 | 0.200 |
Why?
|
| Least-Squares Analysis | 3 | 2017 | 369 | 0.200 |
Why?
|
| Guideline Adherence | 2 | 2010 | 2283 | 0.200 |
Why?
|
| Self Report | 2 | 2013 | 3711 | 0.200 |
Why?
|
| Boston | 8 | 2022 | 9280 | 0.200 |
Why?
|
| Manometry | 1 | 2024 | 453 | 0.200 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 3061 | 0.200 |
Why?
|
| Anorexia Nervosa | 2 | 2024 | 1361 | 0.200 |
Why?
|
| Blood Vessels | 1 | 2007 | 1112 | 0.190 |
Why?
|
| Acceleration | 1 | 2022 | 189 | 0.190 |
Why?
|
| Hospitalization | 8 | 2023 | 10790 | 0.190 |
Why?
|
| Cholesterol | 3 | 2004 | 2924 | 0.190 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 2 | 2020 | 159 | 0.190 |
Why?
|
| Gene Regulatory Networks | 5 | 2024 | 1741 | 0.190 |
Why?
|
| Versicans | 2 | 2019 | 40 | 0.190 |
Why?
|
| Spinal Curvatures | 2 | 2016 | 67 | 0.190 |
Why?
|
| Ultrasonography | 11 | 2022 | 5961 | 0.190 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 2315 | 0.190 |
Why?
|
| Time Factors | 18 | 2020 | 40165 | 0.190 |
Why?
|
| Diet Surveys | 6 | 2022 | 1161 | 0.190 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2021 | 135 | 0.190 |
Why?
|
| Obesity | 10 | 2024 | 12922 | 0.190 |
Why?
|
| Observer Variation | 7 | 2011 | 2601 | 0.180 |
Why?
|
| Acid-Base Equilibrium | 1 | 2001 | 180 | 0.180 |
Why?
|
| Calcifediol | 2 | 2016 | 161 | 0.180 |
Why?
|
| Alleles | 10 | 2014 | 6898 | 0.180 |
Why?
|
| Elder Nutritional Physiological Phenomena | 1 | 2020 | 7 | 0.180 |
Why?
|
| Brassicaceae | 1 | 2020 | 10 | 0.180 |
Why?
|
| Brassica | 1 | 2020 | 40 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6544 | 0.180 |
Why?
|
| Vitamin K Deficiency | 1 | 2000 | 24 | 0.180 |
Why?
|
| Multivariate Analysis | 14 | 2019 | 12159 | 0.180 |
Why?
|
| Apolipoproteins E | 4 | 2014 | 1436 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2002 | 635 | 0.180 |
Why?
|
| Vitamin B 6 | 1 | 2021 | 233 | 0.170 |
Why?
|
| Magnesium | 3 | 2002 | 810 | 0.170 |
Why?
|
| Regression Analysis | 12 | 2018 | 6360 | 0.170 |
Why?
|
| Analysis of Variance | 7 | 2010 | 6238 | 0.170 |
Why?
|
| Hip Joint | 5 | 2012 | 1006 | 0.170 |
Why?
|
| Blood Cells | 2 | 2022 | 305 | 0.170 |
Why?
|
| Logistic Models | 13 | 2022 | 13314 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 10 | 2018 | 10344 | 0.170 |
Why?
|
| Osteocalcin | 3 | 2006 | 274 | 0.170 |
Why?
|
| Musculoskeletal Diseases | 2 | 2024 | 595 | 0.170 |
Why?
|
| Caffeine | 3 | 2014 | 702 | 0.170 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 322 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2000 | 430 | 0.160 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2019 | 30 | 0.160 |
Why?
|
| Antidepressive Agents | 1 | 2011 | 2890 | 0.160 |
Why?
|
| Odds Ratio | 17 | 2022 | 9716 | 0.160 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2019 | 169 | 0.160 |
Why?
|
| Apolipoprotein E2 | 1 | 2019 | 135 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 12293 | 0.160 |
Why?
|
| Access to Information | 1 | 2022 | 320 | 0.160 |
Why?
|
| Haplotypes | 5 | 2021 | 2764 | 0.160 |
Why?
|
| Animals | 33 | 2024 | 167963 | 0.160 |
Why?
|
| Reproducibility of Results | 16 | 2019 | 20080 | 0.150 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2012 | 542 | 0.150 |
Why?
|
| Apolipoprotein E4 | 2 | 2019 | 707 | 0.150 |
Why?
|
| Teriparatide | 3 | 2021 | 227 | 0.150 |
Why?
|
| Organ Size | 7 | 2018 | 2254 | 0.150 |
Why?
|
| Body Weight | 6 | 2023 | 4611 | 0.150 |
Why?
|
| Fracture Fixation | 1 | 2020 | 365 | 0.150 |
Why?
|
| Soft Tissue Injuries | 1 | 2019 | 172 | 0.150 |
Why?
|
| Troponin I | 1 | 2022 | 638 | 0.150 |
Why?
|
| Biomedical Research | 2 | 2011 | 3426 | 0.150 |
Why?
|
| Double-Blind Method | 13 | 2024 | 12427 | 0.150 |
Why?
|
| Musculoskeletal Development | 1 | 2017 | 14 | 0.150 |
Why?
|
| Sex Distribution | 6 | 2010 | 2295 | 0.150 |
Why?
|
| Australia | 4 | 2023 | 1289 | 0.150 |
Why?
|
| Mortality | 6 | 2021 | 2916 | 0.150 |
Why?
|
| Dietary Fiber | 2 | 2021 | 760 | 0.150 |
Why?
|
| Aromatase | 1 | 2018 | 147 | 0.150 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2017 | 55 | 0.150 |
Why?
|
| Back Pain | 3 | 2006 | 543 | 0.150 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2017 | 87 | 0.140 |
Why?
|
| Prevalence | 10 | 2020 | 15687 | 0.140 |
Why?
|
| Motor Activity | 5 | 2015 | 2687 | 0.140 |
Why?
|
| Amidohydrolases | 1 | 2018 | 162 | 0.140 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2016 | 18 | 0.140 |
Why?
|
| Isosorbide Dinitrate | 1 | 2016 | 37 | 0.140 |
Why?
|
| Receptor, EphB2 | 1 | 2016 | 26 | 0.140 |
Why?
|
| Nutrition Disorders | 1 | 1997 | 205 | 0.140 |
Why?
|
| Estrone | 2 | 2018 | 232 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2017 | 313 | 0.140 |
Why?
|
| Atrial Fibrillation | 3 | 2023 | 5209 | 0.140 |
Why?
|
| Femur Head | 1 | 2018 | 297 | 0.140 |
Why?
|
| Drug Utilization Review | 1 | 2017 | 251 | 0.140 |
Why?
|
| Minerals | 2 | 2023 | 283 | 0.140 |
Why?
|
| Goals | 2 | 2024 | 708 | 0.140 |
Why?
|
| Young Adult | 14 | 2024 | 58741 | 0.130 |
Why?
|
| Electric Impedance | 2 | 2019 | 755 | 0.130 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 763 | 0.130 |
Why?
|
| Phospholipase D | 1 | 1996 | 67 | 0.130 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2017 | 183 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 3164 | 0.130 |
Why?
|
| Zygapophyseal Joint | 1 | 2018 | 128 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 5785 | 0.130 |
Why?
|
| Menopause | 4 | 2018 | 1640 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 3 | 2014 | 1067 | 0.130 |
Why?
|
| Oxandrolone | 1 | 2015 | 24 | 0.130 |
Why?
|
| Tooth Loss | 1 | 1998 | 198 | 0.130 |
Why?
|
| Europe | 6 | 2021 | 3441 | 0.130 |
Why?
|
| Fractures, Spontaneous | 3 | 2007 | 231 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 4 | 2007 | 1234 | 0.130 |
Why?
|
| Comorbidity | 8 | 2019 | 10551 | 0.130 |
Why?
|
| Microsatellite Repeats | 3 | 2003 | 786 | 0.130 |
Why?
|
| Tooth | 1 | 1997 | 208 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 1259 | 0.130 |
Why?
|
| Walking | 3 | 2021 | 1189 | 0.130 |
Why?
|
| Office Visits | 1 | 2000 | 597 | 0.130 |
Why?
|
| Posture | 2 | 2010 | 953 | 0.130 |
Why?
|
| Lod Score | 3 | 2012 | 602 | 0.130 |
Why?
|
| Disability Evaluation | 4 | 2020 | 1826 | 0.130 |
Why?
|
| Twins | 1 | 2017 | 339 | 0.130 |
Why?
|
| Cholecalciferol | 2 | 2011 | 550 | 0.130 |
Why?
|
| Diet, Mediterranean | 1 | 2022 | 735 | 0.130 |
Why?
|
| Receptors, Estrogen | 1 | 2003 | 2210 | 0.130 |
Why?
|
| Gene Frequency | 3 | 2017 | 3615 | 0.130 |
Why?
|
| Nitroglycerin | 1 | 2016 | 329 | 0.130 |
Why?
|
| Physical Exertion | 1 | 1998 | 662 | 0.130 |
Why?
|
| Multifactorial Inheritance | 2 | 2020 | 1365 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2022 | 3790 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2013 | 373 | 0.120 |
Why?
|
| Procollagen | 1 | 2015 | 188 | 0.120 |
Why?
|
| Potassium | 1 | 1999 | 1313 | 0.120 |
Why?
|
| Health Services Needs and Demand | 1 | 2022 | 1399 | 0.120 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 992 | 0.120 |
Why?
|
| Geriatrics | 3 | 2019 | 387 | 0.120 |
Why?
|
| Leukocytes | 3 | 2018 | 2026 | 0.120 |
Why?
|
| Life Expectancy | 3 | 2019 | 1248 | 0.120 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 2012 | 78 | 0.120 |
Why?
|
| Geography | 1 | 2016 | 661 | 0.120 |
Why?
|
| Weight Loss | 3 | 2023 | 2686 | 0.110 |
Why?
|
| Pneumonia | 2 | 2020 | 2131 | 0.110 |
Why?
|
| Aortography | 1 | 2015 | 420 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2024 | 4174 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2014 | 286 | 0.110 |
Why?
|
| Case-Control Studies | 13 | 2020 | 22053 | 0.110 |
Why?
|
| Genes, Y-Linked | 1 | 2013 | 12 | 0.110 |
Why?
|
| Extremities | 2 | 2017 | 867 | 0.110 |
Why?
|
| Forecasting | 2 | 2013 | 2932 | 0.110 |
Why?
|
| Knee Joint | 3 | 2007 | 1663 | 0.110 |
Why?
|
| Epigenomics | 1 | 2019 | 936 | 0.110 |
Why?
|
| Research Report | 1 | 2016 | 370 | 0.110 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 670 | 0.110 |
Why?
|
| Exercise Therapy | 4 | 2012 | 919 | 0.110 |
Why?
|
| Reference Standards | 1 | 2016 | 1004 | 0.110 |
Why?
|
| Anabolic Agents | 1 | 2015 | 253 | 0.110 |
Why?
|
| Treatment Outcome | 11 | 2024 | 65017 | 0.110 |
Why?
|
| Yogurt | 1 | 2013 | 71 | 0.110 |
Why?
|
| Placebos | 2 | 2015 | 1668 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 419 | 0.110 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2018 | 701 | 0.110 |
Why?
|
| Arachidonic Acid | 2 | 2011 | 433 | 0.100 |
Why?
|
| Overweight | 1 | 2024 | 2421 | 0.100 |
Why?
|
| Coronary Disease | 4 | 2009 | 5990 | 0.100 |
Why?
|
| Telomerase | 1 | 2018 | 746 | 0.100 |
Why?
|
| Integrin alpha1 | 1 | 2012 | 13 | 0.100 |
Why?
|
| Multiple Sclerosis | 2 | 2018 | 3204 | 0.100 |
Why?
|
| Genes | 2 | 2013 | 1845 | 0.100 |
Why?
|
| Genetics, Population | 1 | 2017 | 930 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2014 | 342 | 0.100 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2012 | 13 | 0.100 |
Why?
|
| Adolescent | 12 | 2024 | 87810 | 0.100 |
Why?
|
| Brachial Artery | 2 | 2024 | 366 | 0.100 |
Why?
|
| GATA Transcription Factors | 1 | 2012 | 29 | 0.100 |
Why?
|
| Mass Screening | 3 | 2020 | 5423 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 978 | 0.100 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2012 | 32 | 0.100 |
Why?
|
| Diuretics | 2 | 2012 | 613 | 0.100 |
Why?
|
| Seafood | 2 | 2015 | 390 | 0.100 |
Why?
|
| Fee-for-Service Plans | 1 | 2017 | 705 | 0.100 |
Why?
|
| Fishes | 2 | 2015 | 601 | 0.100 |
Why?
|
| Collagen Type I | 1 | 2015 | 616 | 0.100 |
Why?
|
| Sensation Disorders | 1 | 2012 | 160 | 0.100 |
Why?
|
| Genetic Association Studies | 3 | 2016 | 2717 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2017 | 4938 | 0.100 |
Why?
|
| Evidence-Based Medicine | 4 | 2020 | 3696 | 0.100 |
Why?
|
| Mice | 13 | 2024 | 81208 | 0.100 |
Why?
|
| Benzothiadiazines | 1 | 1991 | 31 | 0.090 |
Why?
|
| Methyltransferases | 1 | 2014 | 374 | 0.090 |
Why?
|
| France | 1 | 2012 | 511 | 0.090 |
Why?
|
| Immunity | 2 | 2019 | 998 | 0.090 |
Why?
|
| Phosphate Transport Proteins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Genetic Markers | 4 | 2016 | 2608 | 0.090 |
Why?
|
| Severity of Illness Index | 6 | 2017 | 15840 | 0.090 |
Why?
|
| Analgesics | 1 | 2017 | 1065 | 0.090 |
Why?
|
| alpha-Linolenic Acid | 1 | 2011 | 144 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3775 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 7475 | 0.090 |
Why?
|
| Memantine | 1 | 2011 | 105 | 0.090 |
Why?
|
| Phosphatidylcholines | 1 | 2012 | 406 | 0.090 |
Why?
|
| Refusal to Participate | 1 | 2010 | 31 | 0.090 |
Why?
|
| Homeodomain Proteins | 3 | 2015 | 2414 | 0.090 |
Why?
|
| Acids | 1 | 2011 | 125 | 0.090 |
Why?
|
| Societies, Scientific | 1 | 2011 | 221 | 0.090 |
Why?
|
| Dopamine Agents | 1 | 2011 | 189 | 0.090 |
Why?
|
| Osteoarthritis | 1 | 2018 | 1055 | 0.090 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2011 | 240 | 0.090 |
Why?
|
| Quebec | 2 | 2007 | 142 | 0.090 |
Why?
|
| Nootropic Agents | 1 | 2011 | 157 | 0.090 |
Why?
|
| Administration, Oral | 6 | 2023 | 4035 | 0.090 |
Why?
|
| Gene Expression Regulation | 8 | 2019 | 11903 | 0.090 |
Why?
|
| Drinking | 1 | 2011 | 199 | 0.090 |
Why?
|
| Pyrophosphatases | 1 | 2010 | 139 | 0.090 |
Why?
|
| Metacarpus | 4 | 2004 | 36 | 0.090 |
Why?
|
| Patient Selection | 5 | 2010 | 4283 | 0.090 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 225 | 0.080 |
Why?
|
| Calcification, Physiologic | 1 | 2010 | 170 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2014 | 1652 | 0.080 |
Why?
|
| Disease Management | 1 | 2020 | 2514 | 0.080 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2011 | 238 | 0.080 |
Why?
|
| Terminal Care | 1 | 2021 | 1758 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2010 | 199 | 0.080 |
Why?
|
| Protective Agents | 1 | 2010 | 150 | 0.080 |
Why?
|
| Child | 9 | 2021 | 79806 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2002 | 3242 | 0.080 |
Why?
|
| Membrane Proteins | 5 | 2017 | 7850 | 0.080 |
Why?
|
| Family | 2 | 2018 | 3189 | 0.080 |
Why?
|
| C-Reactive Protein | 3 | 2022 | 3839 | 0.080 |
Why?
|
| Outpatients | 1 | 2017 | 1607 | 0.080 |
Why?
|
| Hallux Valgus | 1 | 2009 | 67 | 0.080 |
Why?
|
| Coronary Vessels | 3 | 2024 | 3112 | 0.080 |
Why?
|
| Obesity, Abdominal | 2 | 2023 | 374 | 0.080 |
Why?
|
| Beer | 1 | 2009 | 134 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2001 | 2526 | 0.080 |
Why?
|
| Thyrotropin | 2 | 2012 | 832 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 580 | 0.080 |
Why?
|
| DNA Copy Number Variations | 3 | 2013 | 2013 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 2 | 2018 | 1722 | 0.080 |
Why?
|
| Rehabilitation Centers | 1 | 2010 | 248 | 0.080 |
Why?
|
| Osteogenesis | 2 | 2013 | 1271 | 0.080 |
Why?
|
| Recurrence | 3 | 2012 | 8482 | 0.080 |
Why?
|
| Wine | 1 | 2009 | 167 | 0.080 |
Why?
|
| Medical Audit | 1 | 2010 | 452 | 0.080 |
Why?
|
| Health Services for the Aged | 1 | 1991 | 259 | 0.080 |
Why?
|
| Health | 1 | 2011 | 396 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2013 | 805 | 0.080 |
Why?
|
| Calcitonin | 2 | 2018 | 330 | 0.080 |
Why?
|
| Educational Status | 4 | 2009 | 2515 | 0.080 |
Why?
|
| Interviews as Topic | 3 | 2012 | 2659 | 0.080 |
Why?
|
| Medication Adherence | 2 | 2010 | 2165 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2022 | 12766 | 0.080 |
Why?
|
| Syncope | 1 | 2011 | 428 | 0.080 |
Why?
|
| Accidents | 1 | 1989 | 166 | 0.080 |
Why?
|
| Clodronic Acid | 1 | 2008 | 59 | 0.080 |
Why?
|
| Amides | 1 | 1991 | 448 | 0.080 |
Why?
|
| Metacarpal Bones | 1 | 2008 | 75 | 0.070 |
Why?
|
| Cognition | 4 | 2018 | 6957 | 0.070 |
Why?
|
| Heterozygote | 4 | 2021 | 2798 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 8950 | 0.070 |
Why?
|
| Pressure Ulcer | 1 | 2009 | 156 | 0.070 |
Why?
|
| Cells, Cultured | 6 | 2021 | 18957 | 0.070 |
Why?
|
| Ethanol | 2 | 2009 | 1323 | 0.070 |
Why?
|
| Growth Hormone | 3 | 2001 | 568 | 0.070 |
Why?
|
| Nutrition Assessment | 3 | 2016 | 727 | 0.070 |
Why?
|
| Nutritional Status | 5 | 2013 | 1607 | 0.070 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 1721 | 0.070 |
Why?
|
| Genetic Testing | 2 | 2015 | 3531 | 0.070 |
Why?
|
| Matched-Pair Analysis | 1 | 2008 | 284 | 0.070 |
Why?
|
| Influenza, Human | 1 | 2018 | 1528 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2009 | 534 | 0.070 |
Why?
|
| Rhode Island | 4 | 1998 | 349 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 1047 | 0.070 |
Why?
|
| Standard of Care | 1 | 2011 | 552 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 865 | 0.070 |
Why?
|
| Public Health | 2 | 2019 | 2653 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 1612 | 0.070 |
Why?
|
| Energy Intake | 4 | 2020 | 2129 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2011 | 1493 | 0.070 |
Why?
|
| Stroke | 3 | 2023 | 9962 | 0.070 |
Why?
|
| Health Surveys | 3 | 2020 | 4063 | 0.070 |
Why?
|
| Movement | 2 | 2012 | 1474 | 0.070 |
Why?
|
| Telephone | 1 | 2010 | 624 | 0.070 |
Why?
|
| Potassium, Dietary | 2 | 2009 | 104 | 0.070 |
Why?
|
| Etidronic Acid | 1 | 2006 | 63 | 0.070 |
Why?
|
| Pedigree | 5 | 2007 | 4578 | 0.070 |
Why?
|
| Meat | 2 | 2015 | 584 | 0.070 |
Why?
|
| Exostoses | 1 | 2006 | 30 | 0.070 |
Why?
|
| Phosphoproteins | 2 | 2012 | 2440 | 0.070 |
Why?
|
| Algorithms | 6 | 2016 | 13981 | 0.070 |
Why?
|
| Appointments and Schedules | 1 | 2010 | 442 | 0.070 |
Why?
|
| Materials Testing | 1 | 2009 | 862 | 0.070 |
Why?
|
| Urine | 1 | 1987 | 363 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 1135 | 0.060 |
Why?
|
| Environment | 1 | 2012 | 1118 | 0.060 |
Why?
|
| Pharyngeal Muscles | 1 | 1986 | 81 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2014 | 2488 | 0.060 |
Why?
|
| Mental Status Schedule | 2 | 2005 | 314 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 2250 | 0.060 |
Why?
|
| Arthralgia | 1 | 2009 | 461 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2008 | 484 | 0.060 |
Why?
|
| Intermittent Claudication | 1 | 2008 | 306 | 0.060 |
Why?
|
| Heptanoic Acids | 1 | 2007 | 347 | 0.060 |
Why?
|
| Genetic Heterogeneity | 2 | 2012 | 724 | 0.060 |
Why?
|
| Intelligence | 1 | 2010 | 921 | 0.060 |
Why?
|
| Warfarin | 1 | 2014 | 1518 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2014 | 4357 | 0.060 |
Why?
|
| Hypertension | 2 | 2023 | 8594 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2014 | 542 | 0.060 |
Why?
|
| Age Determination by Skeleton | 1 | 2005 | 126 | 0.060 |
Why?
|
| Morbidity | 3 | 2023 | 1765 | 0.060 |
Why?
|
| New Hampshire | 2 | 2018 | 173 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 1991 | 1411 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 6068 | 0.060 |
Why?
|
| Metabolome | 1 | 2011 | 982 | 0.060 |
Why?
|
| Internal Medicine | 1 | 1991 | 1048 | 0.060 |
Why?
|
| Thiazides | 1 | 2023 | 19 | 0.060 |
Why?
|
| Survival Rate | 4 | 2018 | 12808 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2010 | 1440 | 0.060 |
Why?
|
| Anticoagulants | 2 | 2023 | 4897 | 0.060 |
Why?
|
| Molecular Sequence Annotation | 2 | 2016 | 524 | 0.060 |
Why?
|
| Leg | 1 | 2009 | 1090 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3388 | 0.060 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 5791 | 0.060 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 987 | 0.060 |
Why?
|
| Amlodipine | 1 | 2023 | 84 | 0.060 |
Why?
|
| Population Surveillance | 2 | 2008 | 2608 | 0.060 |
Why?
|
| Muscular Dystrophies | 1 | 1986 | 389 | 0.050 |
Why?
|
| Osteoblasts | 2 | 2021 | 1142 | 0.050 |
Why?
|
| Peptides | 1 | 2015 | 4354 | 0.050 |
Why?
|
| Depression | 1 | 2023 | 8044 | 0.050 |
Why?
|
| Chromosomes, Human, X | 2 | 2018 | 321 | 0.050 |
Why?
|
| Acute Disease | 2 | 2012 | 7269 | 0.050 |
Why?
|
| Anthocyanins | 1 | 2023 | 79 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2021 | 42063 | 0.050 |
Why?
|
| Estrogen Receptor beta | 1 | 2003 | 168 | 0.050 |
Why?
|
| Bread | 1 | 2002 | 23 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2016 | 2809 | 0.050 |
Why?
|
| Osteoclasts | 2 | 2021 | 711 | 0.050 |
Why?
|
| Candy | 1 | 2002 | 36 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 1989 | 1817 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5125 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
| DNA Repair | 1 | 2012 | 2039 | 0.050 |
Why?
|
| Heart | 1 | 2015 | 4393 | 0.050 |
Why?
|
| Biological Evolution | 1 | 2008 | 1074 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2023 | 1523 | 0.050 |
Why?
|
| Safety Management | 1 | 2008 | 760 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 14660 | 0.050 |
Why?
|
| Recovery of Function | 2 | 2021 | 2985 | 0.050 |
Why?
|
| Sampling Studies | 2 | 2012 | 613 | 0.050 |
Why?
|
| Heart Failure | 2 | 2023 | 11847 | 0.050 |
Why?
|
| Patient Dropouts | 1 | 2004 | 412 | 0.050 |
Why?
|
| Vision Disorders | 1 | 1989 | 1084 | 0.050 |
Why?
|
| Restraint, Physical | 2 | 1995 | 186 | 0.050 |
Why?
|
| Oculomotor Muscles | 1 | 1986 | 407 | 0.050 |
Why?
|
| Sulfonylurea Compounds | 1 | 2023 | 221 | 0.050 |
Why?
|
| Urban Population | 1 | 2010 | 2022 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 9411 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2008 | 1168 | 0.050 |
Why?
|
| Epidemiologic Methods | 3 | 2012 | 1343 | 0.050 |
Why?
|
| Receptors, Glucagon | 1 | 2001 | 90 | 0.050 |
Why?
|
| Reference Values | 3 | 2023 | 4925 | 0.050 |
Why?
|
| South America | 1 | 2021 | 181 | 0.050 |
Why?
|
| Hydrazones | 1 | 2001 | 102 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 1189 | 0.050 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2021 | 37 | 0.050 |
Why?
|
| Schools | 1 | 2010 | 1480 | 0.050 |
Why?
|
| Disease Susceptibility | 3 | 2014 | 1791 | 0.050 |
Why?
|
| Pyrroles | 1 | 2007 | 1137 | 0.050 |
Why?
|
| Weight Lifting | 1 | 2001 | 126 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2024 | 1578 | 0.050 |
Why?
|
| Lumbosacral Region | 2 | 2000 | 291 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 107 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2008 | 1992 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 5508 | 0.040 |
Why?
|
| Heel | 1 | 2020 | 37 | 0.040 |
Why?
|
| Equipment Design | 2 | 2009 | 3520 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1617 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2024 | 829 | 0.040 |
Why?
|
| Population Density | 1 | 2021 | 192 | 0.040 |
Why?
|
| Parents | 1 | 2014 | 3549 | 0.040 |
Why?
|
| Hypercholesterolemia | 2 | 2007 | 1155 | 0.040 |
Why?
|
| Prognosis | 6 | 2021 | 29658 | 0.040 |
Why?
|
| Inflammation | 3 | 2023 | 10756 | 0.040 |
Why?
|
| Lung | 2 | 2017 | 9994 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 271 | 0.040 |
Why?
|
| Residence Characteristics | 3 | 2021 | 2062 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2021 | 14372 | 0.040 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2019 | 39 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 1986 | 626 | 0.040 |
Why?
|
| Chronic Disease | 3 | 2020 | 9287 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 266 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 7593 | 0.040 |
Why?
|
| Flavonoids | 1 | 2023 | 445 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2007 | 895 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 9585 | 0.040 |
Why?
|
| Asia | 1 | 2021 | 620 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2011 | 410 | 0.040 |
Why?
|
| Anemia | 1 | 2009 | 1511 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2020 | 1738 | 0.040 |
Why?
|
| Triglycerides | 2 | 2004 | 2476 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 2001 | 1142 | 0.040 |
Why?
|
| Maryland | 1 | 2019 | 275 | 0.040 |
Why?
|
| Psychomotor Performance | 2 | 1998 | 1878 | 0.040 |
Why?
|
| Low Back Pain | 2 | 1998 | 979 | 0.040 |
Why?
|
| Vitamin E | 1 | 2023 | 872 | 0.040 |
Why?
|
| Fish Oils | 2 | 2014 | 482 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2021 | 697 | 0.040 |
Why?
|
| Quality of Life | 4 | 2019 | 13308 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2002 | 292 | 0.040 |
Why?
|
| Nitrogen | 1 | 2020 | 350 | 0.040 |
Why?
|
| Cell Differentiation | 4 | 2021 | 11481 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 4490 | 0.040 |
Why?
|
| Twin Studies as Topic | 1 | 2018 | 104 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2016 | 10182 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 6853 | 0.040 |
Why?
|
| Propensity Score | 2 | 2018 | 1928 | 0.040 |
Why?
|
| Ossification, Heterotopic | 1 | 2001 | 235 | 0.040 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2019 | 128 | 0.040 |
Why?
|
| Radioimmunoassay | 1 | 1998 | 866 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 828 | 0.040 |
Why?
|
| Health Status | 3 | 2013 | 4081 | 0.040 |
Why?
|
| Bicuspid | 1 | 1998 | 69 | 0.040 |
Why?
|
| Curriculum | 1 | 1991 | 3718 | 0.040 |
Why?
|
| Cuspid | 1 | 1998 | 55 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2020 | 5075 | 0.040 |
Why?
|
| Myocardial Infarction | 3 | 2009 | 11891 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1744 | 0.040 |
Why?
|
| Drug Administration Schedule | 3 | 2014 | 4899 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 1991 | 3865 | 0.040 |
Why?
|
| Sample Size | 1 | 2021 | 840 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2002 | 892 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2017 | 135 | 0.040 |
Why?
|
| Troponin T | 1 | 2022 | 774 | 0.040 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2017 | 21 | 0.040 |
Why?
|
| Liver | 4 | 2021 | 7509 | 0.040 |
Why?
|
| Jaw, Edentulous | 1 | 1998 | 99 | 0.040 |
Why?
|
| Molar | 1 | 1998 | 156 | 0.040 |
Why?
|
| Chi-Square Distribution | 3 | 2000 | 3465 | 0.040 |
Why?
|
| Seasons | 3 | 2010 | 1522 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2011 | 3976 | 0.040 |
Why?
|
| Supine Position | 1 | 2017 | 205 | 0.030 |
Why?
|
| Quinacrine | 1 | 1996 | 24 | 0.030 |
Why?
|
| Physical Education and Training | 1 | 1997 | 100 | 0.030 |
Why?
|
| Incisor | 1 | 1998 | 174 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2021 | 1234 | 0.030 |
Why?
|
| Interleukins | 1 | 2021 | 785 | 0.030 |
Why?
|
| Bed Rest | 1 | 2016 | 83 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1398 | 0.030 |
Why?
|
| DNA | 2 | 2000 | 7233 | 0.030 |
Why?
|
| Databases, Factual | 3 | 2018 | 8035 | 0.030 |
Why?
|
| DNA Primers | 1 | 2000 | 2819 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2019 | 814 | 0.030 |
Why?
|
| Western Australia | 1 | 2015 | 41 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 869 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 1894 | 0.030 |
Why?
|
| Benzamides | 1 | 2001 | 1369 | 0.030 |
Why?
|
| Disease Progression | 3 | 2018 | 13502 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2022 | 1535 | 0.030 |
Why?
|
| Indians, North American | 1 | 2019 | 350 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2021 | 965 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2012 | 12103 | 0.030 |
Why?
|
| Pressure | 1 | 2018 | 1156 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2005 | 2912 | 0.030 |
Why?
|
| Physical Stimulation | 1 | 2016 | 518 | 0.030 |
Why?
|
| Stress, Mechanical | 2 | 2011 | 1666 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2018 | 331 | 0.030 |
Why?
|
| Models, Economic | 1 | 2019 | 719 | 0.030 |
Why?
|
| HIV Infections | 1 | 2021 | 17165 | 0.030 |
Why?
|
| Calcium Citrate | 1 | 2014 | 8 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 2015 | 177 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 783 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1628 | 0.030 |
Why?
|
| Personnel Selection | 1 | 1996 | 193 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 22023 | 0.030 |
Why?
|
| Kentucky | 1 | 1994 | 84 | 0.030 |
Why?
|
| Missouri | 1 | 1994 | 114 | 0.030 |
Why?
|
| Tennessee | 1 | 1994 | 119 | 0.030 |
Why?
|
| Receptors, Kainic Acid | 1 | 2014 | 90 | 0.030 |
Why?
|
| Leadership | 1 | 2024 | 1371 | 0.030 |
Why?
|
| Alveolar Bone Loss | 1 | 1998 | 390 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 58 | 0.030 |
Why?
|
| Hypogonadism | 1 | 2000 | 801 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 2005 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 844 | 0.030 |
Why?
|
| Cadaver | 1 | 2018 | 1345 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 57 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2008 | 3127 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 163 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 276 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2013 | 93 | 0.030 |
Why?
|
| Adipocytes | 1 | 2021 | 1179 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2017 | 2981 | 0.030 |
Why?
|
| Fluoroimmunoassay | 1 | 2013 | 30 | 0.030 |
Why?
|
| Clinical Trials as Topic | 3 | 2021 | 8056 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 224 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 2388 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 858 | 0.030 |
Why?
|
| Physicians | 1 | 1991 | 4591 | 0.030 |
Why?
|
| Androgens | 1 | 2021 | 1291 | 0.030 |
Why?
|
| Dehydroepiandrosterone | 1 | 2014 | 257 | 0.030 |
Why?
|
| Preventive Medicine | 1 | 1995 | 250 | 0.030 |
Why?
|
| Myoblasts | 1 | 2014 | 232 | 0.030 |
Why?
|
| Models, Biological | 2 | 2001 | 9467 | 0.030 |
Why?
|
| Length of Stay | 1 | 2007 | 6479 | 0.030 |
Why?
|
| Chickens | 1 | 2015 | 860 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2022 | 2050 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 1998 | 830 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 1356 | 0.030 |
Why?
|
| Zebrafish | 1 | 2024 | 2997 | 0.030 |
Why?
|
| Data Collection | 3 | 2006 | 3315 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2014 | 330 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3334 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 1683 | 0.030 |
Why?
|
| Cytokines | 1 | 2007 | 7343 | 0.030 |
Why?
|
| Self-Evaluation Programs | 1 | 1991 | 29 | 0.030 |
Why?
|
| Risk Management | 1 | 1995 | 558 | 0.030 |
Why?
|
| Weight Gain | 1 | 2002 | 2347 | 0.020 |
Why?
|
| Community Health Services | 1 | 1997 | 654 | 0.020 |
Why?
|
| Software | 2 | 2016 | 4419 | 0.020 |
Why?
|
| Spectrin | 1 | 2012 | 170 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1933 | 0.020 |
Why?
|
| Patient Participation | 1 | 2021 | 1439 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 9185 | 0.020 |
Why?
|
| Gene Expression | 2 | 2017 | 7588 | 0.020 |
Why?
|
| Muscle Development | 1 | 2013 | 259 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 2014 | 372 | 0.020 |
Why?
|
| Telomere | 1 | 2018 | 933 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 1021 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 3448 | 0.020 |
Why?
|
| Wrist Injuries | 1 | 2014 | 214 | 0.020 |
Why?
|
| DNA Primase | 1 | 2012 | 109 | 0.020 |
Why?
|
| Metabolomics | 1 | 2021 | 1628 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1215 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2023 | 3600 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2012 | 146 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 4713 | 0.020 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2011 | 60 | 0.020 |
Why?
|
| Internship and Residency | 1 | 1991 | 5870 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23376 | 0.020 |
Why?
|
| Inositol Phosphates | 1 | 1991 | 176 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 422 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 751 | 0.020 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 1991 | 92 | 0.020 |
Why?
|
| China | 1 | 2016 | 2339 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2015 | 698 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 1991 | 239 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 195 | 0.020 |
Why?
|
| Accidents, Home | 1 | 2010 | 71 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2000 | 3442 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2011 | 149 | 0.020 |
Why?
|
| Markov Chains | 1 | 2013 | 968 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 700 | 0.020 |
Why?
|
| Cell Count | 1 | 2014 | 1835 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2020 | 2963 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 345 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2022 | 3387 | 0.020 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 243 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 253 | 0.020 |
Why?
|
| Ovary | 1 | 2014 | 958 | 0.020 |
Why?
|
| Computational Biology | 2 | 2012 | 3505 | 0.020 |
Why?
|
| Actins | 1 | 2017 | 2049 | 0.020 |
Why?
|
| Physicians, Family | 1 | 1991 | 349 | 0.020 |
Why?
|
| Endonucleases | 1 | 2012 | 370 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 295 | 0.020 |
Why?
|
| Luminescent Measurements | 2 | 2008 | 378 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2010 | 377 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2362 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 1218 | 0.020 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 883 | 0.020 |
Why?
|
| Netherlands | 1 | 2014 | 2213 | 0.020 |
Why?
|
| Shoes | 1 | 2009 | 94 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2011 | 416 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1672 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2014 | 1039 | 0.020 |
Why?
|
| Biopsy | 2 | 2016 | 6771 | 0.020 |
Why?
|
| Flatfoot | 1 | 2009 | 60 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 491 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2013 | 530 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2010 | 478 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 1810 | 0.020 |
Why?
|
| Family Health | 1 | 2013 | 1257 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1602 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 503 | 0.020 |
Why?
|
| Proteins | 2 | 2014 | 6029 | 0.020 |
Why?
|
| Thyroxine | 1 | 2012 | 667 | 0.020 |
Why?
|
| Research | 1 | 1996 | 1974 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 393 | 0.020 |
Why?
|
| Stem Cells | 1 | 2021 | 3523 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2014 | 1195 | 0.020 |
Why?
|
| Glycosuria | 1 | 1987 | 44 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 789 | 0.020 |
Why?
|
| Exercise Test | 1 | 2015 | 2128 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2010 | 639 | 0.020 |
Why?
|
| Pyuria | 1 | 1987 | 30 | 0.020 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2011 | 488 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2023 | 8525 | 0.020 |
Why?
|
| Sexual Maturation | 1 | 2009 | 260 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2018 | 4090 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2009 | 452 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 915 | 0.020 |
Why?
|
| Physicians' Offices | 1 | 1987 | 60 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2008 | 500 | 0.020 |
Why?
|
| Pulmonary Alveoli | 2 | 1987 | 653 | 0.020 |
Why?
|
| Nitrites | 1 | 1987 | 159 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2000 | 6218 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2852 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2014 | 1927 | 0.020 |
Why?
|
| Health Services Research | 1 | 1994 | 1810 | 0.020 |
Why?
|
| Bacteriuria | 1 | 1987 | 103 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 1710 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15697 | 0.020 |
Why?
|
| Receptors, Complement | 1 | 1987 | 253 | 0.020 |
Why?
|
| Immunoassay | 1 | 2010 | 746 | 0.020 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 613 | 0.020 |
Why?
|
| Health Promotion | 2 | 1997 | 2206 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 968 | 0.020 |
Why?
|
| Inpatients | 1 | 2018 | 2581 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2012 | 854 | 0.020 |
Why?
|
| Osteosclerosis | 1 | 2006 | 42 | 0.020 |
Why?
|
| Urination Disorders | 1 | 1987 | 240 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2013 | 2668 | 0.020 |
Why?
|
| Hematuria | 1 | 1987 | 233 | 0.020 |
Why?
|
| gamma-Globulins | 1 | 1985 | 123 | 0.020 |
Why?
|
| Physical Fitness | 2 | 2002 | 732 | 0.020 |
Why?
|
| Neutrophils | 2 | 1991 | 3767 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1987 | 238 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2007 | 298 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 2164 | 0.020 |
Why?
|
| Cephalosporins | 1 | 1986 | 204 | 0.020 |
Why?
|
| Homozygote | 1 | 2010 | 1788 | 0.020 |
Why?
|
| Adiponectin | 1 | 2011 | 1115 | 0.020 |
Why?
|
| Decision Making | 1 | 2019 | 3925 | 0.020 |
Why?
|
| Health Behavior | 1 | 1997 | 2622 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4107 | 0.020 |
Why?
|
| Cell Line | 2 | 2014 | 15620 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3610 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 3442 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 2025 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 4048 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1889 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 877 | 0.020 |
Why?
|
| Syphilis | 1 | 1987 | 241 | 0.010 |
Why?
|
| Canada | 1 | 2010 | 2128 | 0.010 |
Why?
|
| Blepharoptosis | 1 | 1986 | 143 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2016 | 2064 | 0.010 |
Why?
|
| Sunlight | 1 | 2006 | 337 | 0.010 |
Why?
|
| Social Support | 1 | 1994 | 2145 | 0.010 |
Why?
|
| Proteinuria | 1 | 1987 | 594 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2012 | 2208 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2011 | 2698 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 1518 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2011 | 912 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2018 | 3959 | 0.010 |
Why?
|
| Streptococcus agalactiae | 1 | 1985 | 337 | 0.010 |
Why?
|
| International Cooperation | 1 | 2010 | 1433 | 0.010 |
Why?
|
| Macrophages | 3 | 1987 | 5745 | 0.010 |
Why?
|
| Receptors, Fc | 1 | 1987 | 534 | 0.010 |
Why?
|
| Telemedicine | 1 | 2021 | 3018 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1991 | 2913 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2007 | 1249 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2012 | 6381 | 0.010 |
Why?
|
| Phagocytosis | 2 | 1987 | 1535 | 0.010 |
Why?
|
| Cataract | 1 | 1989 | 827 | 0.010 |
Why?
|
| Hippocampus | 1 | 2015 | 3738 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 22072 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2016 | 3476 | 0.010 |
Why?
|
| Disease Models, Animal | 4 | 2015 | 18137 | 0.010 |
Why?
|
| Absorption | 1 | 2002 | 243 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1996 | 2859 | 0.010 |
Why?
|
| Fibronectins | 1 | 1985 | 722 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1997 | 4024 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1987 | 2221 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 3763 | 0.010 |
Why?
|
| Binding Sites | 1 | 2010 | 6048 | 0.010 |
Why?
|
| Biological Availability | 1 | 2002 | 395 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2001 | 366 | 0.010 |
Why?
|
| Digestive System | 1 | 2002 | 244 | 0.010 |
Why?
|
| Primary Health Care | 2 | 2003 | 4647 | 0.010 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2001 | 132 | 0.010 |
Why?
|
| Insulin | 2 | 2012 | 6597 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2873 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 2895 | 0.010 |
Why?
|
| Time | 1 | 2002 | 545 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8624 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2007 | 1827 | 0.010 |
Why?
|
| Structure-Activity Relationship | 2 | 2001 | 3084 | 0.010 |
Why?
|
| Family Practice | 1 | 2003 | 510 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 2002 | 554 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3804 | 0.010 |
Why?
|
| Therapeutic Equivalency | 1 | 2000 | 136 | 0.010 |
Why?
|
| New England | 1 | 2003 | 1050 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2001 | 680 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2012 | 3905 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 7806 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2002 | 11345 | 0.010 |
Why?
|
| Glucagon | 1 | 2001 | 532 | 0.010 |
Why?
|
| Sporothrix | 1 | 1978 | 3 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2018 | 26181 | 0.010 |
Why?
|
| Mitosporic Fungi | 1 | 1978 | 17 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8555 | 0.010 |
Why?
|
| Nasal Cavity | 1 | 2000 | 304 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2000 | 820 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 21025 | 0.010 |
Why?
|
| Ascomycota | 1 | 1978 | 81 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2007 | 2420 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 1850 | 0.010 |
Why?
|
| Brain | 1 | 2024 | 26951 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 1456 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1989 | 4563 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1978 | 818 | 0.010 |
Why?
|
| Lipids | 1 | 2007 | 3336 | 0.010 |
Why?
|
| Monocytes | 1 | 1985 | 2575 | 0.010 |
Why?
|
| Clinical Competence | 1 | 1991 | 4783 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 36060 | 0.010 |
Why?
|
| Fees and Charges | 1 | 1996 | 191 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 7021 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2000 | 1548 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 1993 | 7818 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1987 | 3075 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2005 | 36290 | 0.010 |
Why?
|
| Pain | 1 | 2008 | 5066 | 0.010 |
Why?
|
| Epithelium | 1 | 1997 | 1605 | 0.010 |
Why?
|
| Dogs | 2 | 1987 | 3841 | 0.010 |
Why?
|
| Lymph Nodes | 2 | 1997 | 3486 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2000 | 1190 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 29932 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1997 | 3607 | 0.010 |
Why?
|
| Reaction Time | 1 | 1997 | 2075 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 8158 | 0.010 |
Why?
|
| Cell Division | 1 | 1997 | 4463 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2003 | 3598 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 8552 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1997 | 6216 | 0.000 |
Why?
|
| Health Education | 1 | 1995 | 1049 | 0.000 |
Why?
|
| Staphylococcus aureus | 2 | 1986 | 1462 | 0.000 |
Why?
|
| Peritoneal Cavity | 1 | 1987 | 138 | 0.000 |
Why?
|
| Haemophilus influenzae | 1 | 1986 | 180 | 0.000 |
Why?
|
| Hospitals, Teaching | 1 | 1990 | 1166 | 0.000 |
Why?
|
| Rats | 1 | 2001 | 23711 | 0.000 |
Why?
|
| Macrophage Activation | 1 | 1987 | 554 | 0.000 |
Why?
|
| Endotoxins | 1 | 1986 | 521 | 0.000 |
Why?
|
| Cricetinae | 1 | 1987 | 2427 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1987 | 1600 | 0.000 |
Why?
|
| Hydrogen Peroxide | 1 | 1986 | 732 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1985 | 2558 | 0.000 |
Why?
|
| Biological Transport | 1 | 1986 | 2086 | 0.000 |
Why?
|
| Cell Adhesion | 1 | 1987 | 3094 | 0.000 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1986 | 1949 | 0.000 |
Why?
|
| Shock, Septic | 1 | 1986 | 761 | 0.000 |
Why?
|
| Rhamnose | 1 | 1978 | 18 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1978 | 150 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1985 | 1343 | 0.000 |
Why?
|
| Kinetics | 1 | 1986 | 6377 | 0.000 |
Why?
|
| Mannose | 1 | 1978 | 121 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1978 | 814 | 0.000 |
Why?
|
| Cell Survival | 1 | 1986 | 5797 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1986 | 4219 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1997 | 13262 | 0.000 |
Why?
|
| Rabbits | 1 | 1978 | 4773 | 0.000 |
Why?
|
| Pregnancy | 1 | 1985 | 29749 | 0.000 |
Why?
|